Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

CTRVP

Hepion Pharmaceuticals (PK) (CTRVP)

Hepion Pharmaceuticals Inc (PK)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:CTRVP
DateTimeSourceHeadlineSymbolCompany
01/27/20253:31PMEdgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsUSOTC:CTRVPHepion Pharmaceuticals Inc (PK)
01/27/20253:15PMEdgar (US Regulatory)Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain InvestorsUSOTC:CTRVPHepion Pharmaceuticals Inc (PK)
01/23/20255:03AMEdgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
01/21/202511:15PMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessUSOTC:CTRVPHepion Pharmaceuticals Inc (PK)
01/21/20258:56PMEdgar (US Regulatory)Form S-1MEF - Registration adding securities to prior Form S-1 registration [Rule 462(b)]USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
01/15/20253:15PMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:CTRVPHepion Pharmaceuticals Inc (PK)
01/14/20258:19AMEdgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
12/26/20244:22PMEdgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
11/14/20243:52PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
11/14/20243:07PMEdgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
09/05/20245:36AMEdgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsUSOTC:CTRVPHepion Pharmaceuticals Inc (PK)
09/05/20245:15AMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:CTRVPHepion Pharmaceuticals Inc (PK)
08/13/20242:57PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
07/22/20247:33AMEdgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsUSOTC:CTRVPHepion Pharmaceuticals Inc (PK)
07/22/20247:28AMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:CTRVPHepion Pharmaceuticals Inc (PK)
07/15/202411:15PMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessUSOTC:CTRVPHepion Pharmaceuticals Inc (PK)
07/15/20244:17PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
07/11/20248:46AMEdgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
03/07/20243:15PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:CTRVPHepion Pharmaceuticals Inc (PK)
03/06/20243:30PMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesUSOTC:CTRVPHepion Pharmaceuticals Inc (PK)
02/21/20247:01PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:CTRVPHepion Pharmaceuticals Inc (PK)
02/21/20247:01PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:CTRVPHepion Pharmaceuticals Inc (PK)
02/20/20243:15PMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:CTRVPHepion Pharmaceuticals Inc (PK)
02/07/20243:15PMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:CTRVPHepion Pharmaceuticals Inc (PK)
12/07/20237:41AMEdgar (US Regulatory)Form 8-K - Current reportUSOTC:CTRVPHepion Pharmaceuticals Inc (PK)
11/28/20235:55AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:CTRVPHepion Pharmaceuticals Inc (PK)
11/20/20232:59PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
10/31/20233:15PMEdgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
10/03/20234:22PMEdgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesUSOTC:CTRVPHepion Pharmaceuticals Inc (PK)
10/02/20233:52PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]USOTC:CTRVPHepion Pharmaceuticals Inc (PK)
 Showing the most relevant articles for your search:USOTC:CTRVP